FOSL:NASDAQFossil Group, Inc. Analysis
Data as of 2026-04-04 - not real-time
$4.65
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Fossil Group (FOSL) is trading at $4.65, comfortably above its 20‑day SMA ($4.27) and 50‑day SMA ($4.12), with a bullish MACD histogram (+0.021) and RSI near 60, indicating short‑term momentum is intact. Technical indicators suggest a bullish trend, and the price sits midway between the identified support ($3.77) and resistance ($4.99) levels, leaving room for upside. However, the fundamentals tell a more cautious story: revenue fell 18% YoY, profit margin is negative (-7.8%), and the company posted a Q4 loss of $18.6 million, with trailing EPS of –$1.45. The balance sheet is strained, featuring a debt‑to‑equity ratio of 365% and total debt of $317 million against $102 million of cash, while operating cash flow remains negative. Despite these challenges, free cash flow turned positive ($53.9 million) and the forward EPS projection of $0.095 yields a forward P/E of 48.9, implying the market expects a turnaround. The DCF‑derived fair value of $8.78 translates to a ~50% upside from current levels, and analysts have issued a “strong buy” with a median target of $7, indicating optimism about margin improvements noted in recent earnings calls.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical setup with price above key moving averages
- Recent earnings miss and negative profitability
- High beta and decreasing volume indicating volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential margin expansion highlighted in earnings call
- DCF upside of ~50% and analyst “strong buy” consensus
- Improving free cash flow despite operating cash deficits
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Elevated leverage and negative ROE raise structural concerns
- Consumer cyclical exposure makes earnings sensitive to economic cycles
- Long‑term valuation still attractive relative to fair value estimate
Key Metrics & Analysis
Financial Health
Revenue Growth-18.00%
Profit Margin-7.80%
P/E Ratio48.9
ROE-69.65%
ROA1.98%
Debt/Equity365.36
P/B Ratio2.5
Op. Cash Flow$-57897000
Free Cash Flow$53.9M
Technical Analysis
TrendBullish
RSI59.9
Support$3.77
Resistance$4.99
MA 20$4.27
MA 50$4.12
MA 200$3.00
MACDBullish
VolumeDecreasing
Fear & Greed Index78.8
Valuation
Fair Value$8.78
Target Price$7.00
Upside/Downside50.54%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.72
Volatility77.70%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.